# Stefan Brinkmann

> Stefan Brinkmann is a corporate round investor at Merz Therapeutics backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Merz Therapeutics](https://shizune.co/investors/profile/merz-therapeutics)
- Location: Frankfurt, Germany
- Total investments: 1
- Last investment: Feb 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/stefan-brinkmann-82352a138

Stefan Brinkmann is a corporate round investor at Merz Therapeutics in Frankfurt focused on Health Care and Therapeutics. Stefan Brinkmann is the CEO of Merz Therapeutics. He attended University of Mannheim.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vensica Medical | Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $3M | Corporate Round | Feb 07, 2022 |  |

1 of 1 investments shown.

## About Merz Therapeutics

VC Fund · Frankfurt, Germany

Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to serve unmet patient needs and realize better outcomes.

3 contacts available at Merz Therapeutics.

| Name | Title | Profile |
| --- | --- | --- |
| Stefan Brinkmann | CEO | https://shizune.co/investors/profile/stefan-brinkmann |
| Dan Staner | President, Region Europe | https://shizune.co/investors/profile/dan-staner |
| Stefan König | Chief Executive Officer | https://shizune.co/investors/profile/stefan-k%C3%B6nig |

## Similar investors

### Similar stage
- [Info Edge](https://shizune.co/investors/profile/info-edge) — VC Fund
- [Vector](https://shizune.co/investors/profile/vector-inc-) — VC Fund
- [Akatsuki Games Inc.](https://shizune.co/investors/profile/akatsuki-3) — VC Fund

## FAQ

### What does Stefan Brinkmann invest in?

Stefan Brinkmann invests primarily in Health Care, Therapeutics and Medical Device startups, most often at Corporate Round stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Stefan Brinkmann last invest?

The most recent investment recorded for Stefan Brinkmann closed in Feb 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co